Innovaccer Launches ₹600 Crore ESOP Buyback Program

Healthtech firm Innovaccer has completed an employee stock ownership plan (ESOP) buyback worth ₹600 crore, or around $75 million, as per Entrackr.  

The buyback provided liquidity to current and former employees holding vested stock options and restricted stock units. The company has not disclosed the number of employees who participated in the transaction. 

Background to the Transaction 

The ESOP buyback follows Innovaccer’s $275 million Series F funding round, which included both primary and secondary capital. Investors in the round included B Capital, Kaiser Permanente, and Generation Investment Management. Secondary capital from the round was used to support liquidity for employees. 

Acquisitions in the Past Year 

Over the past year, Innovaccer, led by Abhinav Shashank, completed two acquisitions. It acquired Cured and Pharmacy Quality Solutions. The acquisitions were for adding patient engagement and pharmacy analytics capacity. 

ESOP Activity in Context 

The buyback comes shortly after BrowserStack announced a $125 million ESOP liquidity programme. ESOP buyback activity in 2025 has been limited so far, at just over $75 million. This compares with about $190 million in 2024, $200 million in 2022, $440 million in 2021, and $802 million in 2023. 

About the Company 

Founded in 2014, Innovaccer builds healthcare data and analytics products used by hospitals, health systems and insurers. Its platform helps organisations bring together clinical and operational data for reporting and care coordination.  

The company has a large share of its business in the US healthcare market and works with provider networks and payers. 

For the financial year ended March 2025, Innovaccer reported operating revenue of ₹387.71 crore. The company posted a profit of ₹36.1 crore during the same period.  

Read More: ESOP Buybacks See 9,000+ Employees Make Over $158 Million in 2025! 

Conclusion 

Innovaccer’s ₹600 crore ESOP buyback stands out in a year with fewer employee liquidity events, following its recent fundraise and amid slower ESOP activity across startups. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.   
 
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.